Litcius/Paper detail

An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

Xiaobing Wang, Yi Zhang, Yi Jin, Lie Dai, Yanan Yue, Jiapan Hu, Xin Liu, Kun Pang, Siyuan Ye, Yue Chen, Wenjing Ye, Xiaofei Shi, Xin Ma, Le‐Hang Guo, Yanfang Liu, Na Ta, Xiaofang Zhu, Lin Li, Jiazheng Wang, Ran Yan, Ping Wang, Xiaobin Song, Yixuan Zhou, Lina Zhou, Qing Wang, T. Y. Guan, Ting Li, Ling Zhou, Weihua Pan, Yanran He, Xinyu Wu, Yingyong Xu, Luhan Yang, Huji Xu

2025Cell65 citationsDOI

Topics & Concepts

BiologyMultiple sclerosisCD19ImmunologyAntigenSystemic Sclerosis and Related DiseasesMast cells and histamineInflammatory Myopathies and Dermatomyositis
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis | Litcius